Xavier Dray
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xavier Dray has a total of 195 co-authors. Here are the top co-authors by number of shared publications:
- Philippe Marteau
Société Nationale Française de Gastroentérologie, France
14 shared publications - Gabriel Rahmi
Department of Gastroenterology and Endoscopy, Hôpital Européen Georges-Pompidou, Paris, France
6 shared publications - Philippe Soyer
Department of Radiology, Hôpital Cochin, Assistance Publique-Hopitaux de Paris, France
6 shared publications - Marine Camus
Centre for Digestive Endoscopy, Sorbonne University, Saint-Antoine Hospital, APHP, Paris, France
5 shared publications - Mourad Boudiaf
Department of Body and Interventional Imaging, Hôpital Lariboisière, AP-HP, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France
5 shared publications P. Marteau
Université Sorbonne Paris Cité Paris
5 shared publications
Latest Publications
- 1 June 2018
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 87 (6) , AB149-AB150
Sa1028 TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT
- 1 June 2018
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 87 (6) , AB149-AB150
Sa1028 TERMINOLOGY AND DESCRIPTION OF VASCULAR LESIONS IN SMALL BOWEL CAPSULE ENDOSCOPY: AN INTERNATIONAL DELPHI CONSENSUS STATEMENT
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB546-AB547
Tu1054 Immediate Duodenal Delivery Versus Delayed Oral Ingestion of Capsule Endoscopy: Is the Sooner the Better? a Prospective Comparison of Small Bowel Visualization Quality, According to a Computed Assessment of Cleansing Score
- 1 May 2016
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 83 (5) , AB546-AB547
Tu1054 Immediate Duodenal Delivery Versus Delayed Oral Ingestion of Capsule Endoscopy: Is the Sooner the Better? a Prospective Comparison of Small Bowel Visualization Quality, According to a Computed Assessment of Cleansing Score
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S998
Tu1988 Development of a Small Bowel Capsule Endoscopic Index of Severity in Patients With Crohn's Disease
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S998
Tu1988 Development of a Small Bowel Capsule Endoscopic Index of Severity in Patients With Crohn's Disease
- 1 September 2015
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 96 (9) , 871-883
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features
- 1 September 2015
- Published by Elsevier in Diagnostic and Interventional Imaging
- Vol. 96 (9) , 871-883
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging features
- Open Access
- 1 August 2015
- Published by Wiley in United European Gastroenterology Journal
- Vol. 3 (4) , 313-324
Emerging indications of endoscopic radiofrequency ablation
Introduction: Radiofrequency ablation (RFA) is a well‐validated treatment of dysplastic Barrett's esophagus. Other indications of endoscopic RFA are under evaluation.Results: Four prospective studies (total 69 patients) have shown that RFA achieved complete remission of early esophageal squamous intra‐epithelial neoplasia at a rate of 80%, but with a substantial risk of stricture. In the setting of gastric antral vascular ectasia, two prospective monocenter studies, and a retrospective multicenter study, (total 51 patients), suggest that RFA is efficacious in terms of reducing transfusion dependency. In the setting of chronic hemorrhagic radiation proctopathy, a prospective monocenter study and a retrospective multicenter study (total 56 patients) suggest that RFA is an efficient treatment. A retrospective comparative study (64 patients) suggests that RFA improves stents patency in malignant biliary strictures.Conclusions: Endoscopic RFA is an upcoming treatment modality in early esophageal squamous intra‐epithelial neoplasia, as well as in gastric, rectal, and biliary diseases.
- 1 August 2015
- Published by Wiley in United European Gastroenterology Journal
- Vol. 3 (4) , 313-324
Open AccessEmerging indications of endoscopic radiofrequency ablation
Introduction: Radiofrequency ablation (RFA) is a well‐validated treatment of dysplastic Barrett's esophagus. Other indications of endoscopic RFA are under evaluation.Results: Four prospective studies (total 69 patients) have shown that RFA achieved complete remission of early esophageal squamous intra‐epithelial neoplasia at a rate of 80%, but with a substantial risk of stricture. In the setting of gastric antral vascular ectasia, two prospective monocenter studies, and a retrospective multicenter study, (total 51 patients), suggest that RFA is efficacious in terms of reducing transfusion dependency. In the setting of chronic hemorrhagic radiation proctopathy, a prospective monocenter study and a retrospective multicenter study (total 56 patients) suggest that RFA is an efficient treatment. A retrospective comparative study (64 patients) suggests that RFA improves stents patency in malignant biliary strictures.Conclusions: Endoscopic RFA is an upcoming treatment modality in early esophageal squamous intra‐epithelial neoplasia, as well as in gastric, rectal, and biliary diseases.
- 1 March 2015
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 11 (2) , 483-484
Pouch outlet obstruction by psyllium-based bulk laxative bezoar in a patient with gastric banding
- 1 March 2015
- Published by Elsevier in Surgery for Obesity and Related Diseases
- Vol. 11 (2) , 483-484
Pouch outlet obstruction by psyllium-based bulk laxative bezoar in a patient with gastric banding
- 27 February 2015
- Published by Lavoisier in Acta Endoscopica
- Vol. 45 (3) , 122-131
Indications émergentes de la radiofréquence endoscopique
La radiofréquence (RF) est un traitement validé de l’endobrachyoesophage dysplasique. Cette revue de la littérature a pour objectif d’évaluer les techniques, l’efficacité et les effets indésirables de la RF endoscopique dans d’autres indications, émergentes.
- 27 February 2015
- Published by Lavoisier in Acta Endoscopica
- Vol. 45 (3) , 122-131
Indications émergentes de la radiofréquence endoscopique
La radiofréquence (RF) est un traitement validé de l’endobrachyoesophage dysplasique. Cette revue de la littérature a pour objectif d’évaluer les techniques, l’efficacité et les effets indésirables de la RF endoscopique dans d’autres indications, émergentes.
- 27 February 2015
- Published by Lavoisier in Acta Endoscopica
- Vol. 45 (3) , 115-121
Traitement par radiofréquence de l’endobrachyœsophage
L’endobrachyoesophage (EBO) consiste en une métaplasie intestinale (MI) oesophagienne, dont le risque majeur est l’évolution vers la dysplasie de bas grade (DBG) puis de haut grade (DHG) et finalement l’adénocarcinome oesophagien.
- 27 February 2015
- Published by Lavoisier in Acta Endoscopica
- Vol. 45 (3) , 115-121
Traitement par radiofréquence de l’endobrachyœsophage
L’endobrachyoesophage (EBO) consiste en une métaplasie intestinale (MI) oesophagienne, dont le risque majeur est l’évolution vers la dysplasie de bas grade (DBG) puis de haut grade (DHG) et finalement l’adénocarcinome oesophagien.
- Open Access
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (18) , 5749-50
Transjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia
Gastric antral vascular ectasia (GAVE) may cause gastrointestinal bleeding (GIB). The treatment of GAVE relies on endoscopic approaches such as electrocoagulation (argon plasma coagulation, laser therapy, heater probe therapy, radiofrequency ablation), cryotherapy, and band ligation. In refractory cases, antrectomy may be considered. In the event of an associated cirrhosis and portal hypertension, it has been suggested that antrectomy could be an option, provided the mortality risk isn't considered too great. We report the case of a 67-year-old cirrhotic patient who presented with GAVE related GIB, unresponsive to multiple endoscopic treatments. The patient had a good liver function (model for end-stage disease 10). After a multidisciplinary meeting, a transjugular intrahepatic portosystemic shunt (TIPS) procedure was performed, in order to treat the cirrhosis associated ascites. The outcome was successful. An antrectomy was then performed, with no recurrence of GIB and no transfusion need during three months of follow up. In this case, the TIPS procedure achieved a complete ascites regression, allowing a safer surgical treatment of the GAVE-related GIB.
- 1 January 2015
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (18) , 5749-50
Open AccessTransjugular intrahepatic portosystemic shunt as bridge-to-surgery in refractory gastric antral vascular ectasia
Gastric antral vascular ectasia (GAVE) may cause gastrointestinal bleeding (GIB). The treatment of GAVE relies on endoscopic approaches such as electrocoagulation (argon plasma coagulation, laser therapy, heater probe therapy, radiofrequency ablation), cryotherapy, and band ligation. In refractory cases, antrectomy may be considered. In the event of an associated cirrhosis and portal hypertension, it has been suggested that antrectomy could be an option, provided the mortality risk isn't considered too great. We report the case of a 67-year-old cirrhotic patient who presented with GAVE related GIB, unresponsive to multiple endoscopic treatments. The patient had a good liver function (model for end-stage disease 10). After a multidisciplinary meeting, a transjugular intrahepatic portosystemic shunt (TIPS) procedure was performed, in order to treat the cirrhosis associated ascites. The outcome was successful. An antrectomy was then performed, with no recurrence of GIB and no transfusion need during three months of follow up. In this case, the TIPS procedure achieved a complete ascites regression, allowing a safer surgical treatment of the GAVE-related GIB.